Iván Díaz-Padilla

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Debu Tripathy, Seock‐Ah Im, Marco Colleoni et al. · The Lancet Oncology · 2018 · 973 citations

Advanced Breast Cancer, Breast Oncology, Oncology +11

Incorporation of Pazopanib in Maintenance Therapy of Ovarian Cancer

Andreas du Bois, Anne Floquet, Jae‐Weon Kim et al. · Journal of Clinical Oncology · 2014 · 318 citations · Full text

A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours

Mark T. J. van Bussel, Ahmad Awada, Maja J.A. de Jonge et al. · British Journal of Cancer · 2020 · 117 citations · Full text

Phase 1 study of the ATR inhibitor berzosertib (formerly M6620, VX-970) combined with gemcitabine ± cisplatin in patients with advanced solid tumours

Mark R. Middleton, Emma Dean, T.R. Jeffry Evans et al. · British Journal of Cancer · 2021 · 114 citations · Full text

Phase 1 study of the ATR inhibitor berzosertib in combination with cisplatin in patients with advanced solid tumours

Geoffrey I. Shapiro, Robert Wesolowski, Craig Devoe et al. · British Journal of Cancer · 2021 · 98 citations · Full text